Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.453
EU - Europa 4.543
AS - Asia 2.083
SA - Sud America 139
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 12
Totale 15.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.270
IT - Italia 973
CN - Cina 781
SG - Singapore 771
RU - Federazione Russa 724
DE - Germania 627
SE - Svezia 617
IE - Irlanda 469
UA - Ucraina 424
HK - Hong Kong 217
GB - Regno Unito 208
CA - Canada 172
FI - Finlandia 127
VN - Vietnam 115
BR - Brasile 113
FR - Francia 97
ZA - Sudafrica 68
IN - India 65
AT - Austria 62
NL - Olanda 59
DK - Danimarca 52
TR - Turchia 35
KR - Corea 24
BE - Belgio 21
ES - Italia 18
IR - Iran 18
EU - Europa 16
JP - Giappone 13
EG - Egitto 10
MX - Messico 10
CZ - Repubblica Ceca 9
GR - Grecia 9
AR - Argentina 8
AU - Australia 8
ID - Indonesia 8
CH - Svizzera 7
NO - Norvegia 6
PL - Polonia 6
TH - Thailandia 6
CO - Colombia 5
RO - Romania 5
A1 - Anonimo 4
CL - Cile 4
EC - Ecuador 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
TW - Taiwan 4
VE - Venezuela 4
BD - Bangladesh 3
IL - Israele 3
MD - Moldavia 3
OM - Oman 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
DZ - Algeria 2
HU - Ungheria 2
IQ - Iraq 2
JO - Giordania 2
LT - Lituania 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZM - Zambia 1
Totale 15.337
Salva come PNG Salva come JPEG
Città #
Woodbridge 978
Ann Arbor 953
Houston 709
Fairfield 661
Chandler 605
Singapore 460
Jacksonville 449
Dublin 447
Ashburn 439
Dearborn 369
Wilmington 312
Frankfurt am Main 305
New York 276
Seattle 267
Milan 264
Cambridge 257
Santa Clara 228
Hong Kong 207
Princeton 199
Nanjing 138
Shanghai 101
Altamura 95
Lawrence 82
Lachine 81
Beijing 65
Moscow 65
Nanchang 57
Council Bluffs 56
Dong Ket 55
Vienna 55
Cape Town 51
San Diego 48
Shenyang 46
Guangzhou 43
Helsinki 40
Andover 39
Hebei 37
Ottawa 37
The Dalles 36
Tianjin 32
Jinan 29
Jiaxing 28
Los Angeles 27
Toronto 24
Changsha 22
Lissone 22
Mountain View 22
Boston 20
Fremont 20
Zhengzhou 20
Hangzhou 19
Boardman 17
Chicago 16
London 16
Bologna 14
Brussels 14
Huizen 14
Manchester 14
Ningbo 14
Nürnberg 14
Kunming 13
Norwalk 13
Hefei 12
Rome 12
Munich 10
Valencia 10
Falls Church 9
Washington 9
Dallas 8
Fuzhou 8
Lanzhou 8
Montréal 8
Nuremberg 8
Pune 8
San Francisco 8
Cairo 7
Edmonton 7
Falkenstein 7
Jakarta 7
Napoli 7
Padova 7
Stezzano 7
Taizhou 7
Torino 7
Verona 7
Bonndorf 6
Busto Arsizio 6
San Mateo 6
São Paulo 6
Bari 5
Bergamo 5
Delhi 5
Foggia 5
Ozzano Monferrato 5
Paris 5
Perugia 5
Phoenix 5
Prague 5
Valmadrera 5
Bangkok 4
Totale 10.322
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 331
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 263
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 235
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 219
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 218
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 218
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 213
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 213
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 210
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 208
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 208
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 200
Health Related Quality of Life in the Major Liver Conditions 198
Health related quality of life in chronic liver diseases 198
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 198
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 197
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 196
The impact of liver disease on the health-related quality of life 195
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 192
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 191
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 189
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 186
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 186
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 185
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 185
Light alcohol drinking and cancer: a meta-analysis 185
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 184
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 183
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 180
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 180
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 180
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 179
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 176
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 174
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 174
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 173
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 172
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 172
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 171
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 171
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 169
Re: light drinking has positive public health consequences 169
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 168
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers - A systematic review and meta-analysis 166
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 166
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 165
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 164
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 164
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 163
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 163
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 162
A meta-analysis on alcohol drinking and gastric cancer risk 161
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 160
Incidence of pain after craniotomy in children 159
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 157
Is multifocality a prognostic factor in childhood hepatoblastoma? 156
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 156
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 154
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 153
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 153
Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation 152
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 152
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 150
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 146
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 144
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 143
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 143
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 143
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 143
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 142
A meta-analysis of alcohol consumption and the risk of brain tumours 141
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 139
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 137
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 136
A random-effects meta-regression model for studying nonlinear dose-response relationship 130
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 128
Difference in health related quality of life of chronic liver diseases and general population 128
Donor safety in living donor liver donation: An Italian multicenter survey 128
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 127
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 125
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 124
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 122
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 121
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 120
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 118
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 116
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 112
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 112
Cut-pont finding methods for continuous biomarkers 109
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 107
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 102
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 98
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 98
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 94
Cut-point identification in biomarkers for a censored failure time outcome 93
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 87
Cut-point identification in biomarkers for a censored failure time outcome 86
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 85
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 82
Totale 15.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020215 0 0 0 0 0 0 0 0 0 0 155 60
2020/20211.267 93 83 152 160 84 75 81 88 103 144 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20252.649 227 363 185 127 286 134 164 134 372 448 209 0
Totale 15.877